カスタムアンチセンスオリゴ合成

本ツールでは、長さが15～35ヌクレオチドのアンチセンスオリゴ（ASO）をご注文いただけます。このサイズ外のオリゴについては、custom RNAまたはcustom DNAをご利用ください。

ASO ordering tool

HPLC精製のオプションを使用して、0.05 µmolまたは1.0 µmol合成スケールで15～35塩基のカスタム合成をご注文可能です。
Multiple ASO ordering tool

同じ特性（合成スケール、精製、および修飾）を持つ複数のカスタムアンチセンスオリゴ合成をご注文可能です。

ASOをご所望の際は、Dharmaconのもつ20年以上のオリゴ合成の専門性をご信頼ください。

当社のツールは、ホスホロチオエート結合、2'-O-メチル、ロックされた核酸、MOE（メトキシエチル）修飾など、オリゴの安定性と結合親和性を高める複数の修飾パターンを選択可能です。

また、お客様の実験要件を満たすために、合成スケールと精製オプションの柔軟性もあります。

For more details on Revvity's continued compliance with the United States Framework For Nucleic Acid Synthesis Screening, please see our self-attestation.

siRNAと一本鎖RNAのいずれにも適用できる幅広い化学修飾オプションをご用意しています。

NOTE: オンライン注文ツールから利用できない修飾もあります。サポートが必要な場合は、テクニカルサポートにお問い合わせください。

Filter by:

siRNA
ssRNA
ssRNA-3'
ssRNA-Internal
ssRNA-5'
miRNA
SHOW ALL

Showing modifications available for:

siRNA
ssRNA
ssRNA-3'
ssRNA-Internal
ssRNA-5'
miRNA
All

Standard DNA Bases	Short Code
2'-Deoxy Bases (A, C, G, T) 2'-Deoxy Bases (A, C, G, T) Modification Code: dA, dC, dG, dT Description: DNA modification, typically dTdT, has long been the industry standard for modifying siRNA 3'-overhang, while conferring nuclease resistance and preserving siRNA potency. DNA is well-tolerated in the passage strand with little effects on siRNA potency. Only partially DNA substituted guide strands are functional, whereas alternating the DNA modification with 2'-f has created fully substituted, active guide strands. Unit Structure: Unit Molecular Weight: dA (313.21) dC (289.18) dG (329.21) dT (304.19) References: Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. I, 411, 494-498 (2001). Chiu, Y. L. and Rana, T. M. siRNA function in RNAi: a chemical modification analysis. RNA, 9, 1034-1048 (2003).	A, C, G, T
2'-OMe RNA Bases (A, C, G, U) 2'-OMe RNA Bases (A, C, G, U) Modification Code: mA, mC, mG, mU Description: The naturally occurring 2'-O-methyl (2'-OMe) modification is the first and most extensively tested 2'-substitutions; 2'-OMe slightly enhances the binding affinity toward RNA (Tm increase of 0.5-0.7°C per modification). 2'-OMe modification has been extensively used to generate fully functional siRNAs with higher nuclease resistance, reduced siRNA immunogenicity, and less off-targeting. Unit Structure: Unit Molecular Weight: mA (343.24) mC (319.21) mG (359.23) mU (320.19) References: Soutschek, J. et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature, 432, 173-178 (2004). Allerson, C. R. et al. Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J. Med. Chem, 48, 901-904 (2005).	mA,mC,mG,mU
5' Modifications	Short Code
5'-Cholesterol 5'-Cholesterol Modification Code: Chl Description: Potential therapeutic oligonucleotides must permeate the cell membrane for optimal activity. The addition of lipophilic groups such as cholesterol to a siRNA enhances gene silencing in vivo. Efficient and selective uptake of cholesterol siRNA conjugates depends on interactions with lipoprotein particles, lipoprotein receptors and transmembrane proteins. High-density lipoprotein (HDL) directs siRNA delivery into liver, gut, kidney and steroidogenic organs, whereas low-density lipoprotein (LDL) targets siRNA primarily to the liver. Unit Structure: Unit Molecular Weight: 624.00 References: Mackellar, C. et al. Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups. Nucleic Acid Res. 20, 3411-3417 (1992). Wolfrum, C. et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nature Biotechnology 25, 1149-1157 (2007).	Chl
5'-Fluorescein 5'-Fluorescein Modification Code: Fl Description: Fluorescein is often used in fluorescence experiments to demonstrate the kinetics of folding or substrate binding. Fluorescein is also used as a donor to track optimal changes related to folding or substrate binding to intermolecular interactions. Fluorescein-labeled siRNAs can be used to visualize cellular uptake of siRNA and to quantify siRNA transfection/delivery efficiency. Unit Structure: Unit Molecular Weight: 538.47 Extinction Coefficient: 75,000 Excitation/Emission Max: 494 nm/525 nm	Fl
Internal Modifications	Short Code
Phosphorothioate Phosphorothioate Modification Code: * Description: A classic and popular phosphate backbone modification is the phosphorothioate (PS) modification where one of the non-bridging phosphate oxygens is replaced with sulfur. Phosphorothioates have been widely used in antisense and siRNA applications. The majority of therapeutic oligonucleotides contain this modification which is introduced to increase nuclease resistance and facilitate cellular uptake and bioavailability in vivo. Unit Structure: Unit Molecular Weight: 15.97 (additional MW where sulfur replacing oxygen) References: Kurreck, J. The role of backbone modifications in oligonucleotide-based strategies, in Therapeutic Oligonucleotides (Kurreck, J. ed.), RSC Publishing, pp 1-22 (2008). Eckstein, F. Phosphorothioates, essential components of therapeutic oligonucleotides. Nucleic Acid Ther. 24, 274-287 (2014).	*
2'-Fluoro-adenosine 2'-Fluoro-adenosine Modification Code: 2'-F-A Description: 2'-Fluoro-nucleosides adopt an RNA-type sugar conformation, presumably due to the high electronegativity of fluorine. Fluorine substitution (2'-F) slightly stabilizes dsRNA duplex (~1°C in Tm per modification). 2'-F substitution is among the best tolerated modification types and therefore allows the creation of highly modified, active siRNAs, both strands tolerate 2'-F modifications at most positions and substitution of all siRNA pyrimidines was reported to greatly enhance serum stability and to effective support silencing in vitro and in vivo. Unit Structure: Unit Molecular Weight: 331.20 References: Chiu, Y. L. and Rana, T. M. siRNA function in RNAi: a chemical modification analysis. RNA, 9, 1034-1048 (2003).	2'-F-A
2'-Fluoro-cytidine 2'-Fluoro-cytidine Modification Code: 2'-F-C Description: 2'-Fluoro-nucleosides adopt an RNA-type sugar conformation, presumably due to the high electronegativity of fluorine. Fluorine substitution (2'-F) slightly stabilizes dsRNA duplex (~1 °C in Tm per modification). 2'-F substitution is among the best tolerated modification types and therefore allows the creation of highly modified, active siRNAs, both strands tolerate 2'-F modifications at most positions and substitution of all siRNA pyrimidines was reported to greatly enhance serum stability and to effective support silencing in vitro and in vivo. Unit Structure: Unit Molecular Weight: 307.17 References: Chiu, Y. L. and Rana, T. M. siRNA function in RNAi: a chemical modification analysis. RNA, 9, 1034-1048 (2003).	2'-F-C
2'-Fluoro-guanosine 2'-Fluoro-guanosine Modification Code: 2'-F-G Description: 2'-Fluoro-nucleosides adopt an RNA-type sugar conformation, presumably due to the high electronegativity of fluorine. Fluorine substitution (2'-F) slightly stabilizes dsRNA duplex (~1 °C in Tm per modification). 2'-F substitution is among the best tolerated modification types and therefore allows the creation of highly modified, active siRNAs, both strands tolerate 2'-F modifications at most positions and substitution of all siRNA pyrimidines was reported to greatly enhance serum stability and to effective support silencing in vitro and in vivo. Unit Structure: Unit Molecular Weight: 347.20 References: Chiu, Y. L. and Rana, T. M. siRNA function in RNAi: a chemical modification analysis. RNA, 9, 1034-1048 (2003).	2'-F-G
2'-Fluoro-uridine 2'-Fluoro-uridine Modification Code: 2'-F-U Description: 2'-Fluoro-nucleosides adopt an RNA-type sugar conformation, presumably due to the high electronegativity of fluorine. Fluorine substitution (2'-F) slightly stabilizes dsRNA duplex (~1 °C in Tm per modification). 2'-F substitution is among the best tolerated modification types and therefore allows the creation of highly modified, active siRNAs, both strands tolerate 2'-F modifications at most positions and substitution of all siRNA pyrimidines was reported to greatly enhance serum stability and to effective support silencing in vitro and in vivo. Unit Structure: Unit Molecular Weight: 308.16 References: Chiu, Y. L. and Rana, T. M. siRNA function in RNAi: a chemical modification analysis. RNA, 9, 1034-1048 (2003).	2'-F-U
5-Methyl-Deoxycytidine 5-Methyl-deoxycytidine Modification Code: 5-M-dC Description: The nucleobase modification 5-methylcytosine (5-mC) is widespread both in DNA and different cellular RNAs. 5-Methyl-cytosine enhances DNA or RNA duplex stability by elevating melting temperature 0.5 - 1.3°C per addition. Unit Structure: Unit Molecular Weight: 303.21 References: Freier, S. M. and Altmann, K.-H. The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically modified DNA:RNA duplexes. Nucleic Acid Res. 25, 4429-4443 (1997).	5-M-dC
Adenosine Locked Nucleic Acid	A-LNA
Cytidine (5-methyl-deoxy-cytidine) Locked Nucleic Acid	5mC-LNA
Guanosine Locked Nucleic Acid	G-LNA
Thymidine Locked Nucleic Acid	T-LNA
2′-O-Methoxy-ethyl-Adenosine	moeA
2’-O-Methoxy-ethyl-5-Methyl-Cytidine	moe5MeC
2′-O-Methoxy-ethyl-Guanosine	moeG
2’-O-Methoxy-ethyl-Thymidine	moeT
3' Modifications	Short Code
3'-Cholesterol 3'-Cholesterol Modification Code: 3'-Chl Description: Potential therapeutic oligonucleotides must permeate the cell membrane for optimal activity. The addition of lipophilic groups such as cholesterol to a siRNA enhances gene silencing in vivo. Efficient and selective uptake of cholesterol siRNA conjugates depends on interactions with lipoprotein particles, lipoprotein receptors and transmembrane proteins. High-density lipoprotein (HDL) directs siRNA delivery into liver, gut, kidney and steroidogenic organs, whereas low-density lipoprotein (LDL) targets siRNA primarily to the liver. Unit Structure: Unit Molecular Weight: 705.94 References: Mackellar, C. et al. Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups. Nucleic Acid Res. 20, 3411-3417 (1992). Wolfrum, C. et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nature Biotechnology 25, 1149-1157 (2007).	3'-Chl
N-acetyl-galactosamine	GalNAc
3’TEG-Cholesterol	TEG-Chl-3’